LL-37
Cathelicidin Antimicrobial Peptide LL-37
The only known human cathelicidin antimicrobial peptide. Part of the innate immune system with broad antimicrobial activity and wound-healing properties.
Typical Cost
$80-150/vial (5mg)
Status
Research
Peptide Profile
LL-37
Mechanism of Action
Disrupts bacterial membranes, exhibits antimicrobial activity against bacteria, fungi, and viruses. Promotes wound healing, angiogenesis, and modulates immune responses.
Common Dosages
subcutaneous
100-500mcg
Daily or 3x weekly · 4-8 weeks
topical
10-50mcg/mL
2x daily · Until healed
Benefits
Antimicrobial activity
Wound healing
Immune modulation
Broad-spectrum protection
Biofilm disruption
Side Effects
Limited human data
Potential autoimmune activation
Injection site reactions
Key Research
LL-37 antimicrobial activity
Broad-spectrum antimicrobial activity against pathogens
LL-37 wound healing
Accelerated wound healing and angiogenesis
Regulatory Status
Research chemical only. Natural human peptide. Not FDA-approved for therapeutic use.
Contraindications
- ⚠Autoimmune conditions
- ⚠Pregnancy/breastfeeding
GLP-1 users with immune concerns may consider alongside SeraVia's immune-supporting nutrients.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.